Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Bellwether Wuxi Biologics' Plunge Indicative Of China Biotech Challenges
Forecasts Hauled Back
Dec 07 2023
•
By
Brian Yang
WuXi Biologics reports rare revenue miss, share prices plunge underscores broader biotech sector downturn • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from China
More from Focus On Asia